U.S. Markets open in 2 hrs 32 mins

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.01-0.06 (-0.99%)
At close: 4:00PM EDT
People also watch
SGENIMMUEXELINCYCLDX
  • B
    BobDole
    BobDole
    Hmmm not sure what to say about this stock right now. The 1 month chart shows lower lows, lower highs. That's usually a bearish move.
  • A
    Abigail
    Abigail
    My guess is that IMGN is due for a pullback in the short-run. check out awesom_sto-cks, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • T
    Tony
    Tony

    MicroCap News Alert: - Startup - Clean Energy Technologies (CETY) buys General Electric “Heat Recovery Systems Division” and within 2 years achieves break-even with sales now set to soar and to be profitable.

    CETY announced today the launch of Pacific Rim Initiative with over 20 locations already identified by CETY and PPA power company authorities.

    Early orders likely to exceed $25 million in annuitized sales. 12 month target price $.25

    CETY/GE proprietary oil-free magnetic levitation turbine technology shatters the competition’s old oil-lubricated screw expander technologies.

    Company expects to up list to NASDAQ.

    CETY's implementation includes creative lease financing structure, that facilitates rapid adoption and ease of entry with long-term payment structure that allows the utility user to align its investment with actual energy and cost savings realized through use of Clean Cycle™ units," said Kam Mahdi, CEO of CETY.

    CETY being welcomed with red carpet to largest markets in the world in need of clean energy.

    https://finance.yahoo.com/news/clean-energy-technologies-cety-launches-131500960.html

    Clean Energy Technologies (CETY) Launches Pacific Rim Initiative
    COSTA MESA, Calif. , Aug. 15, 2017 Clean Energy Technologies, Inc. (OTC: CETY) announced that CETY officially launched its new campaign to deliver its energy solutions to Island Nations utilities at the ...
    finance.yahoo.com
  • B
    BobDole
    BobDole
    Uptrend appears unbroken. Stock didn't want to stay down yesterday.
  • J
    John D
    John D
    Why is it that most reports about this company are slanted to the negative? Why don't they tout the 6 company owned products and the 16 partnerships?
    One article stated that they had missed their projections three quarters in a row-fakenews?????

    John D
  • J
    Jarad
    Jarad

    This is where I find the top NASDAQ & NYSE Trade Ideas ---> www.T0pm@rketgainers.c0m

  • M
    Max
    Max
    Time to sell above 6! This stock is likely to end up flat again today, unable to hold any gains.
  • j
    jim
    jim
    Any scientists here? Anyone agrees with their notion that CD33 is not the reason for SGEN's failure?
  • B
    BobDole
    BobDole
    Sold at 6.11, rebought at 5.82. WEEE!!!!!!
  • B
    BobDole
    BobDole
    I think we'll see $6+ today. 5% increase gets us to $6.11. I think we might settle around $6.05 today (slightly under 4%)
  • A
    Alexis
    Alexis
    If we are to go off the RSI then you could argue that a pull back next day or so could occur on IMGN before rallying up. the other week awe*some*sto-cks alerted this company i think. google them .
  • B
    BobDole
    BobDole
    Too early to shout "HEEIIILL YEAH!" ?
  • B
    BobDole
    BobDole

    Reiterate buy from Jefferies.
    http://www.analystratings.com/articles/jefferies-reaffirms-their-buy-rating-on-immunogen/

    Per https://www.tipranks.com/analysts/top the top 25 analysts are usually from Jefferies and RBC Capital.

    Jefferies Reaffirms Their Buy Rating on ImmunoGen - Analyst Ratings
    August 7, 2017 Jefferies analyst Michael Yee reiterated a Buy rating on ImmunoGen (NASDAQ: IMGN) yesterday and set a price target of $9. The company's shares closed on Fr
    www.analystratings.com
  • M
    Mike
    Mike
    I am betting this stock won't make it to years end without being bought out. This company has many drugs in various places in the pipeline, it is absolutely a buyout target, and buying with these short attacks is almost too easy, your about to watch this run in my opinion, either way short or long GLTA
  • B
    BobDole
    BobDole

    American Bulls confirmed buy on 8/7
    https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=IMGN

    Error Page
    Errorpage
    www.americanbulls.com
  • B
    BobDole
    BobDole
    Thanks for the cheap shares, whoever's manipulating this stock. Bought in high 5s, rode it to mid 7s and sold. Back for more. Suckas! Gotta have balls to play with the big boys.
  • G
    Good
    Good
    I have not seen a pipeline like this for another company with this size of market cap. This will fly and fly high. Hang in there, buy more on dips.
  • B
    BobDole
    BobDole

    This may be why a lot of biotech stocks are shooting up today. It's even better when the stock's been manipulated a lot since shorts now are panicking to cover.
    http://www.marketwatch.com/story/united-therapeutics-corp-stock-surges-9-on-report-of-possible-bids-for-company-2017-08-04-8914713

    United Therapeutics Corp. stock surges 9% on report of possible bids for company
    www.marketwatch.com
  • T
    Trinity
    Trinity
    If we are to go off the RSI then you could argue that a pull back next day or so could occur on IMGN before rallying up. Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from Awe.Some.Sto-ck.s.
  • J
    JJ
    JJ
    no worries. this is going 12 at least this year.